[go: up one dir, main page]

SE0003125D0 - Modified polymers - Google Patents

Modified polymers

Info

Publication number
SE0003125D0
SE0003125D0 SE0003125A SE0003125A SE0003125D0 SE 0003125 D0 SE0003125 D0 SE 0003125D0 SE 0003125 A SE0003125 A SE 0003125A SE 0003125 A SE0003125 A SE 0003125A SE 0003125 D0 SE0003125 D0 SE 0003125D0
Authority
SE
Sweden
Prior art keywords
water
soluble
modified
polysaccharide
soluble polysaccharide
Prior art date
Application number
SE0003125A
Other languages
English (en)
Inventor
Marianne Eklund
Jan-Eric Loefroth
Urban Skantze
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0003125A priority Critical patent/SE0003125D0/sv
Publication of SE0003125D0 publication Critical patent/SE0003125D0/sv
Priority to EP01963156A priority patent/EP1322293B1/en
Priority to AU2001284189A priority patent/AU2001284189A1/en
Priority to PCT/GB2001/003861 priority patent/WO2002019990A1/en
Priority to JP2002524475A priority patent/JP2004508322A/ja
Priority to ES01963156T priority patent/ES2272527T3/es
Priority to US10/362,261 priority patent/US20040022850A1/en
Priority to AT01963156T priority patent/ATE340564T1/de
Priority to DE60123447T priority patent/DE60123447T2/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE0003125A 2000-09-05 2000-09-05 Modified polymers SE0003125D0 (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE0003125A SE0003125D0 (sv) 2000-09-05 2000-09-05 Modified polymers
EP01963156A EP1322293B1 (en) 2000-09-05 2001-08-30 Modified release formulation
AU2001284189A AU2001284189A1 (en) 2000-09-05 2001-08-30 Modified release formulation
PCT/GB2001/003861 WO2002019990A1 (en) 2000-09-05 2001-08-30 Modified release formulation
JP2002524475A JP2004508322A (ja) 2000-09-05 2001-08-30 放出修飾製剤
ES01963156T ES2272527T3 (es) 2000-09-05 2001-08-30 Formulacion de liberacion modificada.
US10/362,261 US20040022850A1 (en) 2000-09-05 2001-08-30 Modified release formulation
AT01963156T ATE340564T1 (de) 2000-09-05 2001-08-30 Arzneimittel mit verzögerter wirkstoffabgabe
DE60123447T DE60123447T2 (de) 2000-09-05 2001-08-30 Arzneimittel mit verzögerter wirkstoffabgabe

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0003125A SE0003125D0 (sv) 2000-09-05 2000-09-05 Modified polymers

Publications (1)

Publication Number Publication Date
SE0003125D0 true SE0003125D0 (sv) 2000-09-05

Family

ID=20280889

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0003125A SE0003125D0 (sv) 2000-09-05 2000-09-05 Modified polymers

Country Status (9)

Country Link
US (1) US20040022850A1 (sv)
EP (1) EP1322293B1 (sv)
JP (1) JP2004508322A (sv)
AT (1) ATE340564T1 (sv)
AU (1) AU2001284189A1 (sv)
DE (1) DE60123447T2 (sv)
ES (1) ES2272527T3 (sv)
SE (1) SE0003125D0 (sv)
WO (1) WO2002019990A1 (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0201661D0 (sv) 2002-05-31 2002-05-31 Astrazeneca Ab New salts
SE0201659D0 (sv) * 2002-05-31 2002-05-31 Astrazeneca Ab Modified release pharmaceutical formulation
ES2605414T3 (es) 2005-03-02 2017-03-14 Hercules Incorporated Hidroxietilcelulosa soluble en agua de sustitución de baja, sus derivados, procedimiento de obtención y sus usos
BR112013000233A2 (pt) 2010-07-28 2021-05-18 Dow Global Technologies Llc método para controlar ou ajustar a liberação de um ingrediente ativo e uso de um controle de diluente em uma composição
CN109790226B (zh) * 2016-09-29 2022-05-03 住友精化株式会社 水溶性羟乙基纤维素的制造方法
WO2019183470A2 (en) 2018-03-22 2019-09-26 Incarda Therapeutics, Inc. A novel method to slow ventricular rate

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3965256A (en) * 1972-05-16 1976-06-22 Synergistics Slow release pharmaceutical compositions
JPS5163927A (en) * 1974-11-28 1976-06-02 Shinetsu Chemical Co Ketsugoseiryokonajozaihokaizaino seizohoho
US4097606A (en) * 1975-10-08 1978-06-27 Bristol-Myers Company APAP Tablet containing an alkali metal carboxymethylated starch and processes for manufacturing same
US4063017A (en) * 1976-04-22 1977-12-13 Purdue Research Foundation Porous cellulose beads and the immobilization of enzymes therewith
US4024335A (en) * 1976-05-04 1977-05-17 Union Carbide Corporation Homogeneous hydroxy-alkylation of cellulose
AR241633A1 (es) * 1982-12-30 1992-10-30 Goemar Lab Sa Procedimiento para la preparacion de un extracto fisiologico de algas o plantas.
GB8613689D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
US4851233A (en) * 1986-10-06 1989-07-25 Warner-Lambert Company Sustained release formulations
FR2634397B2 (fr) * 1986-12-31 1991-04-19 Centre Nat Rech Scient Procede de preparation de systemes colloidaux dispersibles d'une proteine sous forme de nanoparticules
BR8806902A (pt) * 1987-04-16 1989-10-31 Christian Bindschaedler Processo para preparacao de um po de polimero insoluvel em agua que pode ser redispersado em uma fase liquida,po resultante e sua utilizacao
US5004613A (en) * 1987-07-27 1991-04-02 Mcneil-Ppc, Inc. Oral sustained release pharmaceutical formulation and process
US4820522A (en) * 1987-07-27 1989-04-11 Mcneilab, Inc. Oral sustained release acetaminophen formulation and process
US5073380A (en) * 1987-07-27 1991-12-17 Mcneil-Ppc, Inc. Oral sustained release pharmaceutical formulation and process
US5066793A (en) * 1987-10-26 1991-11-19 Ciba-Geigy Corporation Finely particulate cellulose esters of aromatic or aromatic-aliphatic carboxylic acids, process for their preparation, and the use thereof
US4892739A (en) * 1988-04-25 1990-01-09 Ciba-Geigy Corporation Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having a improved core membrane adhesion properties
AT395724B (de) * 1990-12-07 1993-02-25 Chemiefaser Lenzing Ag Verfahren zur herstellung von celluloseformkoerpern
US5550189A (en) * 1992-04-17 1996-08-27 Kimberly-Clark Corporation Modified polysaccharides having improved absorbent properties and process for the preparation thereof
EP0665010B1 (en) * 1992-10-16 2002-09-11 Nippon Shinyaku Company, Limited Method of manufacturing wax matrices
EP0676967A4 (en) * 1992-12-30 1996-10-02 Fmc Corp RELEASED, EXTENDED, EASY TO PRODUCE EXCIPIENT, BASED ON KONJAC GLUCOMANNANE.
US5451409A (en) * 1993-11-22 1995-09-19 Rencher; William F. Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends
FI972305A7 (sv) * 1994-12-01 1997-05-30 Cibus Pharmaceutical Inc Administrering av NSAID genom att använda finmalet hydrokolloidgummi u tvunnet ur högre växter
JPH10509981A (ja) * 1994-12-01 1998-09-29 サイバス ファーマシューティカル，インコーポレイティド 高等植物から得られうる粉末状親水コロイドゴムを用いる持効性薬剤送出
US6063402A (en) * 1995-06-07 2000-05-16 Venture Lending, A Division Of Cupertino National Bank Purified galactomannan as an improved pharmaceutical excipient
US6652882B1 (en) * 1997-10-06 2003-11-25 Intellipharmaceutics Corp Controlled release formulation containing bupropion

Also Published As

Publication number Publication date
ES2272527T3 (es) 2007-05-01
WO2002019990A1 (en) 2002-03-14
EP1322293A1 (en) 2003-07-02
US20040022850A1 (en) 2004-02-05
ATE340564T1 (de) 2006-10-15
DE60123447T2 (de) 2007-08-23
AU2001284189A1 (en) 2002-03-22
JP2004508322A (ja) 2004-03-18
DE60123447D1 (de) 2006-11-09
EP1322293B1 (en) 2006-09-27

Similar Documents

Publication Publication Date Title
BRPI0509827B8 (pt) nanopartículas pegiladas para transporte de moléculas biologicamente ativas, composição farmacêutica, liofilizato constituindo nanopartículas pegiladas e processo de preparação de nanopartículas pegiladas
NZ527585A (en) Tablets quickly disintegrated in oral cavity
DK1149116T3 (da) Fremgangsmåde til fremstilling af multipelt tværbundne hyaluronsyrederivater
PT1083884E (pt) Processo para a estabilizacao de composicoes de polivinil-pirrolidona
CY1107838T1 (el) Παραγωγα αδαμαντανιου για τη θεραπεια φλεγμονωδων, ανοσολογικων και καρδιαγγειακων ασθενειων
HRP20070432A2 (en) Gastroresistant pharmaceutical formulations containing rifaximin
NO20070719L (no) Tablettformulering med forlenget frigivelse som inneholder pramipeksol eller et farmasoytisk akseptabelt salt derav, fremgangsmate for fremstilling av den og anvendelse derav
WO2007008752A3 (en) Sustained release pharmaceutical compositions for highly water soluble drugs
TR200102314T2 (tr) Damar gelişimi inhibitörleri olarak kuinazolin türevleri.
MXPA05007163A (es) Derivados polimericos de acido maleamico y sus bioconjugados.
SE9904505D0 (sv) Novel compounds
DE69924004D1 (de) Verabreichungssystem für wasserunlösliche arzneistoffe
NO20023551D0 (no) Ibuprofen-inneholdende aktivt middel-preparat
SE0003125D0 (sv) Modified polymers
CN104173356A (zh) 肝适能固态分散物、包括其的药的组成物以及其制备方法
DE60017444D1 (de) Pharmazeutische formulierungen auf basis fester dispersionen
DK1263413T3 (da) Fremgangsmåde til fremstilling af faste dispersioner
BR0012735A (pt) Preparação solida, e, processo para produzir preparações
BR0112258A (pt) Sistema de entrega de droga para drogas pouco solúveis em água
NO20076120L (no) Stabile nanopartikkelformuleringer
MD20180043A2 (ro) Procedeu de obţinere a unui conjugat de hialuronidază cu derivaţi ai polietilenpiperazinei şi aplicarea conjugatului obţinut
DE50005082D1 (de) Verfahren zu Herstellung von PULVERFÖRMIGEn SOLUBILISATIONSHILFSSTOFFEn FÜR FESTE PHARMAZEUTISCHE DARREICHUNGSFORMEN
ATE374600T1 (de) Pharmazeutische formulierung enthaltend olanzapin
NZ584968A (en) Novel antiretroviral combination comprising ritonavir and atazanavir
NO20054417L (no) Fremgangsmate for fremstilling av farmasoytiske preperater i form av fibratholdige tabletter og de derved fremstilte tabletter